Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Persky

Showing results (691-700 of 711) with videos related to

Pageof 72
Sort By:
Nature Structural & Molecular Biology|January 12, 2020
Defining the landscape of ATP-competitive inhibitor resistance residues in protein kinasesN S Persky, D Hernandez, M Do Carmo, et al.
Anticancer Research|December 11, 2013
Long-term outcome of seropositive HIV patients with head and neck squamous cell carcinoma treated with radiation therapy and chemotherapyWaleed F Mourad, Kenneth S Hu, Daniel Shasha, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 23, 2020
Broad host range of SARS-CoV-2 predicted by comparative and structural analysis of ACE2 in vertebratesJoana Damas, Graham M Hughes, Kathleen C Keough, et al.
Blood|July 13, 2014
Phase 2 study of imexon, a prooxidant molecule, in relapsed and refractory B-cell non-Hodgkin lymphomaPaul M Barr, Thomas P Miller, Jonathan W Friedberg, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 8, 2018
Phase I Study of the Investigational Aurora A Kinase Inhibitor Alisertib plus Rituximab or Rituximab/Vincristine in Relapsed/Refractory Aggressive B-cell LymphomaKevin R Kelly, Jonathan W Friedberg, Steven I Park, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 14, 2020
Positron Emission Tomography-Directed Therapy for Patients With Limited-Stage Diffuse Large B-Cell Lymphoma: Results of Intergroup National Clinical Trials Network Study S1001Daniel O Persky, Hongli Li, Deborah M Stephens, et al.
Cell Metabolism|August 6, 2019
Fatty Acid Metabolites Combine with Reduced β Oxidation to Activate Th17 Inflammation in Human Type 2 DiabetesDequina A Nicholas, Elizabeth A Proctor, Madhur Agrawal, et al.
Genome Biology|December 1, 2024
Functional screening reveals genetic dependencies and diverging cell cycle control in atypical teratoid rhabdoid tumorsDaniel J Merk, Foteini Tsiami, Sophie Hirsch, et al.
British Journal of Haematology|May 21, 2020
Checkpoint blockade treatment sensitises relapsed/refractory non-Hodgkin lymphoma to subsequent therapyNicole A Carreau, Philippe Armand, Reid W Merryman, et al.
Nature|July 13, 2022
Structure-function analysis of the SHOC2-MRAS-PP1C holophosphatase complexJason J Kwon, Behnoush Hajian, Yuemin Bian, et al.
Pageof 72

Showing results (691-700 of 711) with videos related to

Sort By:
Pageof 72
Nature Structural & Molecular Biology|January 12, 2020
Defining the landscape of ATP-competitive inhibitor resistance residues in protein kinasesN S Persky, D Hernandez, M Do Carmo, et al.
Anticancer Research|December 11, 2013
Long-term outcome of seropositive HIV patients with head and neck squamous cell carcinoma treated with radiation therapy and chemotherapyWaleed F Mourad, Kenneth S Hu, Daniel Shasha, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 23, 2020
Broad host range of SARS-CoV-2 predicted by comparative and structural analysis of ACE2 in vertebratesJoana Damas, Graham M Hughes, Kathleen C Keough, et al.
Blood|July 13, 2014
Phase 2 study of imexon, a prooxidant molecule, in relapsed and refractory B-cell non-Hodgkin lymphomaPaul M Barr, Thomas P Miller, Jonathan W Friedberg, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 8, 2018
Phase I Study of the Investigational Aurora A Kinase Inhibitor Alisertib plus Rituximab or Rituximab/Vincristine in Relapsed/Refractory Aggressive B-cell LymphomaKevin R Kelly, Jonathan W Friedberg, Steven I Park, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 14, 2020
Positron Emission Tomography-Directed Therapy for Patients With Limited-Stage Diffuse Large B-Cell Lymphoma: Results of Intergroup National Clinical Trials Network Study S1001Daniel O Persky, Hongli Li, Deborah M Stephens, et al.
Cell Metabolism|August 6, 2019
Fatty Acid Metabolites Combine with Reduced β Oxidation to Activate Th17 Inflammation in Human Type 2 DiabetesDequina A Nicholas, Elizabeth A Proctor, Madhur Agrawal, et al.
Genome Biology|December 1, 2024
Functional screening reveals genetic dependencies and diverging cell cycle control in atypical teratoid rhabdoid tumorsDaniel J Merk, Foteini Tsiami, Sophie Hirsch, et al.
British Journal of Haematology|May 21, 2020
Checkpoint blockade treatment sensitises relapsed/refractory non-Hodgkin lymphoma to subsequent therapyNicole A Carreau, Philippe Armand, Reid W Merryman, et al.
Nature|July 13, 2022
Structure-function analysis of the SHOC2-MRAS-PP1C holophosphatase complexJason J Kwon, Behnoush Hajian, Yuemin Bian, et al.
Pageof 72